BamSEC and AlphaSense Join Forces
Learn More

Aytu BioPharma Inc.

NASDAQ: AYTU    
Share price (1/3/25): $1.77    
Market cap (1/3/25): $10.9 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 15 pages Amended and Re-Stated Employment Agreement
12/34/56
EX-10.42
from 10-K 11 pages Amended and Re-Stated Employment Agreement
12/34/56
EX-10.1
from 10-Q 34 pages Certain Confidential Information Contained in This Document, Marked by [***], Has Been Omitted Because It Is Both (I) Not Material and (II) Is the Type That the Registrant Treats as Private and Confidential. Commercial Manufacturing Services Agreement
12/34/56
EX-10.55
from 10-K 14 pages Amended and Re-Stated Employment Agreement ​
12/34/56
EX-10.54
from 10-K 6 pages Sixth Amendment to Lease
12/34/56
EX-10.53
from 10-K 10 pages Fifth Amendment to Lease
12/34/56
EX-10.52
from 10-K 10 pages Fourth Amendment to Lease
12/34/56
EX-10.51
from 10-K 11 pages Third Amendment to Lease
12/34/56
EX-10.50
from 10-K 5 pages Interim Amendment to Lease
12/34/56
EX-10.49
from 10-K 20 pages First Amendment to Lease
12/34/56
EX-10.48
from 10-K 45 pages Trammell Crow Company Commercial Lease Agreement Walstib, L.P., a Delaware Limited Partnership Landlord and Pharmafab, Inc. Tenant
12/34/56
EX-10.47
from 10-K 12 pages ​ Sublease
12/34/56
EX-10.46
from 10-K 13 pages Amended and Re-Stated Employment Agreement
12/34/56
EX-10.45
from 10-K 10 pages ​ Amended and Re-Stated Employment Agreement
12/34/56
EX-10.1
from S-8 17 pages Aytu Biopharma, Inc. 2023 Equity Incentive Plan
12/34/56
EX-10.43
from S-1/A 41 pages Securities Purchase Agreement
12/34/56
EX-10.42
from S-1/A 20 pages Placement Agency Agreement , 2023
12/34/56
EX-10.3
from 10-Q 25 pages Certain Confidential Information Contained in This Document, Marked by [***], Has Been Omitted Because It Is the Type That the Registrant Treats as Private or Confidential Settlement and Termination of License Agreement
12/34/56
EX-10.1
from 8-K 13 pages Indemnification Agreement
12/34/56
EX-10.1
from 10-Q 25 pages Certain Confidential Information Contained in This Document, Marked by [***], Has Been Omitted Because It Is the Type That the Registrant Treats as Private or Confidential Settlement and Termination of License Agreement
12/34/56